Kudrna's Stock Market Talk

With the recent volatility in Cord Blood America (CBAI), I’ve been emailed frequently on my thoughts of this stock possibly recovering.  (more…)

Cord Blood America (CBAI) had a run-up last week and it appears most of the bulls are still holding even while the price falls.  As long as this continues, we can likely expect another big run-up sometime soon and likely higher than the recent run-up as more buyers enter.  (more…)

We seem to have found a new wave of pumpers in GoIP Global (GOIG) blinding new shareholders once again.  As I stated before, this company has a great concept with a terrible driver behind the wheel.  I love the concept, I always have, but I have no trust in Ike Sutton anymore. (more…)

Every now and then, I will post some homework on various stocks that have been talked about in the chatroom or that I actively discuss on the site to help readers find useful tidbits of info/articles easier. (more…)

Every now and then, I will post some homework on various stocks that have been talked about in the chatroom or that I actively discuss on the site to help readers find useful tidbits of info/articles easier. (more…)

From time to time, I will update readers on popular charts we discuss in the chat or that I am asked about through my contact page on here and Seeking Alpha/Twitter.  Tonight, I’m going to briefly discuss the charts for GoIP Global (GOIG), Sirius XM (SIRI), and Thresher Industries (THRR). (more…)

I’m excited today to update readers on two core positions in the portfolio.  Cord Blood America (CBAI), utilizing the Schissler Factor, went on a two day streak of positive PR’s.  First with an acquisition of controlling interest in a profitable South American stem cell storage company, BioCells, and today stating they have signed a Definitive Supplier Agreement with a well-respected, accredited, tissue bank providing placenta collection services for therapeutic transplantation, and are already filling orders. (more…)

To the surprise of many, Cord Blood America (CBAI) has not seen the boost we’ve all come to expect even after an acquisition. We are the same price we were before the acquisition.  With the numerous amount of positive PR’s as of late, one would have expected a more solid move towards $.02.  Unfortunately, that has not happened.  When the news isn’t cutting it, we have no choice but to look to the charts for guidance. (more…)

Good evening everyone.  Quick update to readers in regards to Cord Blood America (CBAI).  We received more details today in an interview with Matt Schissler, CEO, which can be found here.  The main points I took from the interview are a projected increase in revenues for CBAI of about 20-30% and that they will have more acquisitions in the future, but when is uncertain.  Also of note was Schissler stating, “We believe this is one of the most significant stem cell storage companies in Europe and it already has begun to establish sales channels in Italy and Spain.” (more…)

Good evening readers.  For those of you who had been buying up shares of Cord Blood America (CBAI) alongside me these past few weeks, you were pleasantly surprised to see the acquisition seems to have come to fruition after much anticipation.  CBAI announced they acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany.  I’m very happy that this acquisition finally took place and look forward to hearing more details over the coming days or weeks about what stellacure brings to the table in regards to current and estimated revenues/growth.  With financials being released around the corner, roughly 3-4 weeks, we are sure to hear more details.  I will be closely monitoring as I am very anxious to know more. (more…)